IL-33 mediates inflammatory responses in human lung tissue cells

Area of Science:

• Immunology
• Respiratory Medicine
• Cell Biology

Background:

• Interleukin-33 (IL-33) is an IL-1 family member mediating effects through the ST2 receptor.
• ST2 receptor is found on Th2 cells and mast cells.
• The role of IL-33 in direct lung tissue cell responses in airway remodeling is unclear.

Purpose of the Study:

• Identify IL-33-responsive cells within primary human lung tissue.
• Investigate the mechanism of IL-33 action on these cells.
• Explore the involvement of IL-33 in asthmatic airway inflammation.

Main Methods:

• Assessed ST2 mRNA expression in lung endothelial, epithelial, fibroblast, and smooth muscle cells.
• Measured IL-8 production by these cells in response to IL-33.
• Utilized ST2 small interference RNA to confirm receptor involvement.
• Examined the effects of IL-4 and corticosteroids on IL-33 responses.
• Analyzed MAPK signaling pathways (ERK, p38) activation.

Main Results:

• ST2 mRNA and IL-33-induced IL-8 production were observed in endothelial and epithelial cells, but not fibroblasts or smooth muscle cells.
• ST2 receptor mediates IL-33-dependent IL-8 upregulation in these cells.
• Th2 cytokines (e.g., IL-4) enhanced ST2 expression and function.
• Corticosteroids partially suppressed IL-33 effects on endothelial cells and nearly completely on epithelial cells.
• IL-33 activated ERK and p38 MAPK in endothelial cells, and ERK in epithelial cells, with specific MAPK involvement in IL-8 production.

Conclusions:

• IL-33 acts directly on human lung endothelial and epithelial cells via the ST2 receptor.
• These IL-33-mediated inflammatory responses may contribute to chronic allergic inflammation in asthma.
• Differential MAPK activation and corticosteroid sensitivity highlight distinct cellular responses.